ViiV Healthcare is the world’s  only pharmaceutical company dedicated exclusively to HIV, and in this episode, Ben meets its CEO, Deborah Waterhouse, to explore the company’s approach to HIV R&D and commercial success - as well as the controversies its global access strategy has attracted for its new long acting injectables. Deborah and Ben find they have much in common beyond both being Brits growing up in the 70s and 80s, from being students of the humanities choosing to make careers in health, to their favorite pop music. 

https://viivhealthcare.comhttps://www.unaids.org/enhttps://www.who.int/health-topics/hiv-aidshttps://www.cdc.gov/hiv/default.htmlhttps://au.int/en/sa/oid

#ViiV #pharma #HIV #AIDS #treatment #Prevention #PrEP #dualtherapy #longacting #injectables #globalaccess #globalequity #discrimination #positiveaction #womenleaders #IWD